ADVISORY/David Singer, President & CEO, GeneSoft, Inc., ''Bio-Tech Weapons: Life or Death?''.News/Assignment Editors ADVISORY...for Wednesday (Jan. 10) --(BUSINESS WIRE)
When: January 10, 2001 7:15 - 9:00 a.m.
Where: Santa Clara Westin Hotel -- Tasman & Great America Parkway
What: SC University CIE's CEO Global Breakfast Series
GeneSoft, Inc. is a biotech pharmaceutical company pioneering the discovery and development of novel therapeutics and a new class of marketable drugs to treat a broad range of gene-mediated diseases -- such as infectious disease Infectious disease A pathological condition spread among biological species. Infectious diseases, although varied in their effects, are always associated with viruses, bacteria, fungi, protozoa, multicellular parasites and aberrant proteins known as prions. and cancer. Yet while David Singer, GeneSoft's president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , and other "good guys" aim bio-technology towards wellness, the "bad guys" seek its dark side. Terrorists using smallpox, anthrax, or embola viruses or replicating the Japanese subway attack of several years ago exemplify the use-as-weaponry aspect. Come to the breakfast and hear Mr. Singer's perspectives on both the promise and the threat. Before GeneSoft, David was SVP SVP S'il Vous Plaît (French: Please) SVP Senior Vice President SVP Schweizerische Volkspartei (Swiss People~s Party) SVP Society of Vertebrate Paleontology SVP Social Venture Partners SVP St Vincent de Paul & CFO See Chief Financial Officer. at Heartport and also held senior spots at Affymetrix, Affymax, N.V. and Baxter International. He holds a BA from Yale and an MBA MBA abbr. Master of Business Administration Noun 1. MBA - a master's degree in business Master in Business, Master in Business Administration from Stanford University |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion